{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:57:16Z","timestamp":1777071436695,"version":"3.51.4"},"reference-count":22,"publisher":"BMJ","issue":"2","funder":[{"name":"The Netherlands Organization for Health Research and Development, ZonMw","award":["11-32010-02"],"award-info":[{"award-number":["11-32010-02"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2023,8,17]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To explore clinical effect modifiers of systemic hydrocortisone in ventilated very preterm infants for survival and neurodevelopmental outcome at 2\u2009years\u2019 corrected age (CA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Secondary analysis of a randomised placebo-controlled trial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Dutch and Belgian neonatal intensive care units.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>Infants born &lt;30 weeks\u2019 gestational age (GA), ventilator-dependent in the second week of postnatal life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>Infants were randomly assigned to systemic hydrocortisone (cumulative dose 72.5\u2009mg\/kg; n=182) or placebo (n=190).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>The composite of death or neurodevelopmental impairment (NDI) at 2\u2009years\u2019 CA and its components. Candidate effect modifiers (GA, small for GA, respiratory index, sex, multiple births, risk of moderate\/severe bronchopulmonary dysplasia or death) were analysed using regression models with interaction terms and subpopulation treatment effect pattern plots.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The composite outcome was available in 356 (96.0%) of 371 patients (one consent withdrawn). For this outcome, treatment effect heterogeneity was seen across GA subgroups (&lt;27 weeks: hydrocortisone (n=141) vs placebo (n=156), 54.6% vs 66.2%; OR 0.61 (95% CI 0.38 to 0.98); \u226527 weeks: hydrocortisone (n=30) vs placebo (n=31), 66.7% vs 45.2%; OR 2.43 (95% CI 0.86 to 6.85); p=0.02 for interaction). This effect was also found for the component death (&lt;27 weeks: 20.1% vs 32.1%; OR 0.53 (95% CI 0.32 to 0.90); \u226527 weeks: 28.1% vs 16.1%; OR 2.04 (95% CI 0.60 to 6.95); p=0.049 for interaction) but not for the component NDI. No differential treatment effects were observed across other subgroups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This secondary analysis suggests that in infants &lt;27 weeks\u2019 GA, systemic hydrocortisone may improve the outcome death or NDI, mainly driven by its component death. There was insufficient evidence for other selected candidate effect modifiers.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/archdischild-2023-325558","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T13:20:26Z","timestamp":1695043226000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Identifying effect modifiers of systemic hydrocortisone treatment initiated 7\u201314 days after birth in ventilated very preterm infants on long-term outcome: secondary analysis of a randomised controlled trial"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6588-2265","authenticated-orcid":false,"given":"Nienke Marjolein","family":"Halbmeijer","sequence":"first","affiliation":[{"name":"Neonatology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Research Institute, Amsterdam Reproduction and Development, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Sonnaert","sequence":"additional","affiliation":[{"name":"Neonatology, Universitair Ziekenhuis Brussel, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate M","family":"Swarte","sequence":"additional","affiliation":[{"name":"Neonatology, Erasmus MC Sophia Children's Hospital, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corine","family":"Koopman-Esseboom","sequence":"additional","affiliation":[{"name":"Neonatology, University Medical Centre Utrecht\/Wilhelmina Children's Hospital, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margriet","family":"van Stuijvenberg","sequence":"additional","affiliation":[{"name":"Neonatology, University Medical Centre Groningen, Beatrix Children's Hospital, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Mulder-de Tollenaer","sequence":"additional","affiliation":[{"name":"Neonatology, Isala Medical Centre, Zwolle, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratna N G B","family":"Tan","sequence":"additional","affiliation":[{"name":"Neonatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thilo","family":"Mohns","sequence":"additional","affiliation":[{"name":"Neonatology, Maxima Medical Centre, Women Mother and Child Centre, Veldhoven, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Bruneel","sequence":"additional","affiliation":[{"name":"Neonatology, Ziekenhuis Oost-Limburg, Genk, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Steiner","sequence":"additional","affiliation":[{"name":"Neonatology, Radboudumc Institute for Health Sciences, Amalia Children's Hospital, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris W","family":"Kramer","sequence":"additional","affiliation":[{"name":"School of Women\u2019s and Infants\u2019 Health, University of Western Australia, Crawley, Western Australia, Australia"},{"name":"Research & Development, Neuroplast BV, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Debeer","sequence":"additional","affiliation":[{"name":"Neonatology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam M","family":"van Weissenbruch","sequence":"additional","affiliation":[{"name":"Research Institute, Amsterdam Reproduction and Development, Amsterdam, The Netherlands"},{"name":"Neonatology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoann","family":"Marechal","sequence":"additional","affiliation":[{"name":"Neonatology, Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Blom","sequence":"additional","affiliation":[{"name":"Neonatology, Universitair Ziekenhuis Antwerpen, Edegem, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katleen","family":"Plaskie","sequence":"additional","affiliation":[{"name":"Neonatology, St Augustinus ziekenhuis, Antwerp, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4402-5299","authenticated-orcid":false,"given":"Martin","family":"Offringa","sequence":"additional","affiliation":[{"name":"Neonatology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Neonatology and Child Health Evaluative Sciences, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maruschka P","family":"Merkus","sequence":"additional","affiliation":[{"name":"Epidemiology and Data Science, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wes","family":"Onland","sequence":"additional","affiliation":[{"name":"Neonatology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Research Institute, Amsterdam Reproduction and Development, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleid G","family":"Leemhuis","sequence":"additional","affiliation":[{"name":"Neonatology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Research Institute, Amsterdam Reproduction and Development, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton H","family":"van Kaam","sequence":"additional","affiliation":[{"name":"Neonatology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Research Institute, Amsterdam Reproduction and Development, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"key":"2025090509394380000_109.2.159.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10244"},{"key":"2025090509394380000_109.2.159.2","first-page":"184","article-title":"Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely Preterm infants in the US, 2013-2018","volume":"42","author":"Bell","year":"2022","journal-title":"Jama"},{"key":"2025090509394380000_109.2.159.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.01.043"},{"key":"2025090509394380000_109.2.159.4","article-title":"Late (\u2265 7 days) systemic postnatal corticosteroids for prevention of Bronchopulmonary dysplasia in Preterm infants","volume":"11","author":"Doyle","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090509394380000_109.2.159.5","article-title":"Early (< 7 days) systemic postnatal corticosteroids for prevention of Bronchopulmonary dysplasia in Preterm infants","volume":"10","author":"Doyle","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090509394380000_109.2.159.6","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-1-1","article-title":"The adverse neuro-developmental effects of postnatal steroids in the Preterm infant: a systematic review of Rcts","volume":"1","author":"Barrington","year":"2001","journal-title":"BMC Pediatr"},{"key":"2025090509394380000_109.2.159.7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clp.2013.09.006","article-title":"Steroids and injury to the developing brain: Net harm or net benefit?","volume":"41","author":"Malaeb","year":"2014","journal-title":"Clin Perinatol"},{"key":"2025090509394380000_109.2.159.8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.101.5.e7","article-title":"Early dexamethasone therapy in Preterm infants: a follow-up study","volume":"101","author":"Yeh","year":"1998","journal-title":"Pediatrics"},{"key":"2025090509394380000_109.2.159.9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/jama.2018.21443","article-title":"Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or Bronchopulmonary dysplasia among very Preterm infants receiving mechanical ventilation: A randomized clinical trial","volume":"321","author":"Onland","year":"2019","journal-title":"JAMA"},{"key":"2025090509394380000_109.2.159.10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.2021.9380","article-title":"Effect of systemic hydrocortisone initiated 7 to 14 days after birth in ventilated","volume":"326","author":"Halbmeijer","year":"2021","journal-title":"Jama"},{"key":"2025090509394380000_109.2.159.11","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-11-102","article-title":"Systemic hydrocortisone to prevent Bronchopulmonary dysplasia in Preterm infants (the stop-BPD study); a multicenter randomized placebo controlled trial","volume":"11","author":"Onland","year":"2011","journal-title":"BMC Pediatr"},{"key":"2025090509394380000_109.2.159.12","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-018-2505-y","article-title":"Systemic hydrocortisone to prevent Bronchopulmonary dysplasia in Preterm infants (the stop-BPD study): statistical analysis plan","volume":"19","author":"Onland","year":"2018","journal-title":"Trials"},{"key":"2025090509394380000_109.2.159.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2006.05.002"},{"key":"2025090509394380000_109.2.159.14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpeds.2021.12.018","article-title":"Severity of Bronchopulmonary dysplasia and neurodevelopmental outcome at 2 and 5 years corrected age","volume":"243","author":"Katz","year":"2022","journal-title":"J Pediatr"},{"key":"2025090509394380000_109.2.159.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201101-0055OC"},{"key":"2025090509394380000_109.2.159.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.07.049"},{"key":"2025090509394380000_109.2.159.17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1740774516643297","article-title":"Subpopulation treatment effect pattern plot (STEPP) analysis for continuous, binary, and count outcomes","volume":"13","author":"Yip","year":"2016","journal-title":"Clinical Trials"},{"key":"2025090509394380000_109.2.159.18","doi-asserted-by":"publisher","DOI":"10.1177\/1740774515609106"},{"key":"2025090509394380000_109.2.159.19","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j3448","article-title":"Neurodevelopmental outcome at 2 years for Preterm children born at 22 to 34 weeks\u2019 gestation in France in 2011: EPIPAGE-2 cohort study","volume":"358","author":"Pierrat","year":"2017","journal-title":"BMJ"},{"key":"2025090509394380000_109.2.159.20","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2014.3351"},{"key":"2025090509394380000_109.2.159.21","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-313756"},{"key":"2025090509394380000_109.2.159.22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-0597"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2023-325558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T16:39:57Z","timestamp":1757090397000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2023-325558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,19]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/archdischild-2023-325558"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2023-325558","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]}}}